Depletion of Tregs using PC61 anti-CD25 mAb resulted in no significant reduction of epidermal thickness and Th1/2 cytokines such as IL-4, IL-13, IFN-γ, and IL-6 in bvPLA2-treated AD mice. The gene discussed is NELFCD; the disease is Alzheimer disease.